NCT00056472View on ClinicalTrials.gov

Study of Pharmacotherapy of Psychotic Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Major Depressive Disorder With Psychotic Features
Interventions
DRUG

Olanzapine

10-20mg/day

DRUG

Sertraline

150-200mg/day

OTHER

placebo

tablet that ressembles sertraline but contains no medication

Trial Locations (4)

10021

Cornell University, New York

15213

University of Pittsburgh, Pittsburgh

01605

University of Massachusetts Medical School, Worcester

M5G 2C4

University of Toronto, Toronto

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT00056472 - Study of Pharmacotherapy of Psychotic Depression | Biotech Hunter | Biotech Hunter